Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
608 A phase I clinical trial of a personalized neoantigen vaccine in PD-1 inhibitor refractory metastatic melanoma
2025
0 citations
Journal Article
hybrid Open Access
Field-Weighted Citation Impact:
0.00
University of Washington
Natalie Miller
·
University of Washington
Kelly G. Paulson
·
Swedish Medical Center
Frank Schmitz
·
Amazon (United States)
Antje Heit
·
Amazon (United States)
Tianzi Zhang
·
Fred Hutch Cancer Center
Alessandro Rizzi
·
Fred Hutch Cancer Center
Mauro Iuliano
·
Fred Hutch Cancer Center
Brandon Seaton
·
Fred Hutch Cancer Center
Gargi Roy
·
Foundation for Health Care Quality
Bo Lee
·
Fred Hutch Cancer Center
Lauren Martin
·
Fred Hutch Cancer Center
Melanie Walker
·
Amazon (United States)
Alessandra Harley
·
Stanford Medicine
Anta Imata Safo
·
Amazon (United States)
Samuel A. Danziger
·
Amazon (United States)
Haibao Tang
·
Amazon (United States)
Mỹ Loan Phụng Lê
·
Fred Hutch Cancer Center
Layne C. Price
·
Amazon (United States)
Gil Sadeh
·
Amazon (United States)
Brandon Hoane
·
Amazon (United States)
Sean Stockwell
·
Amazon (United States)
Beshoy Sarkis
·
Amazon (United States)
Nick Levato
·
Amazon (United States)
Abhishek Vaidya
·
Amazon (United States)
Neeraj Sood
·
Amazon (United States)
Cecilia C.S. Yeung
·
Fred Hutch Cancer Center
Evan W. Newell
·
Fred Hutch Cancer Center
Roland K. Strong
·
Fred Hutch Cancer Center
David Heckerman
·
Amazon (United States)
Aude G. Chapuis
·
Fred Hutch Cancer Center
608 A phase I clinical trial of a personalized neoantigen vaccine in PD-1 inhibitor refractory metastatic melanoma | Researchclopedia